Process View
Any process that decreases the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of cell substrate adhesion"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| JAG1 | jagged 1 | 0.953 | ||
| ENG | endoglin | 0.749 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.674 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.636 | ||
| NOTCH1 | notch 1 | 0.610 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.578 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.453 | ||
| PLAU | plasminogen activator, urokinase | 0.421 | Human | |
| HOXB5 | homeobox B5 | 0.411 | Human | |
| DLG1 | discs, large homolog 1 (Drosophila) | 0.358 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.340 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.335 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.322 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.319 | ||
| ABI2 | abl-interactor 2 | 0.245 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.186 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.144 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.137 | Human | |
| NOTCH3 | notch 3 | 0.116 | Human | |
| SMAD7 | SMAD family member 7 | 0.103 | ||
| HOXA5 | homeobox A5 | 0.101 | Human | |
| PLAT | plasminogen activator, tissue | 0.096 | Human | |
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.095 | ||
| HOXB7 | homeobox B7 | 0.094 | Human | |
| HOXA7 | homeobox A7 | 0.090 | ||
| RXRA | retinoid X receptor, alpha | 0.089 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.089 | ||
| THBS1 | thrombospondin 1 | 0.088 | ||
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.087 | ||
| NRP1 | neuropilin 1 | 0.077 | ||
| FN1 | fibronectin 1 | 0.075 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.074 | ||
| HOXC6 | homeobox C6 | 0.073 | Human | |
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.073 | ||
| SDC2 | syndecan 2 | 0.070 | ||
| HOXB6 | homeobox B6 | 0.069 | Human | |
| WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 | 0.068 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.067 | ||
| GDF5 | growth differentiation factor 5 | 0.063 | ||
| INADL | InaD-like (Drosophila) | 0.057 | ||
| SH3PXD2A | SH3 and PX domains 2A | 0.056 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.055 | ||
| DLL1 | delta-like 1 (Drosophila) | 0.053 | ||
| WNT5A | wingless-type MMTV integration site family, member 5A | 0.053 | Human | |
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.052 | ||
| HOXB3 | homeobox B3 | 0.051 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.051 | Human | |
| HOXA11 | homeobox A11 | 0.051 | ||
| LIN7C | lin-7 homolog C (C. elegans) | 0.050 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.049 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.049 | ||
| HOXA10 | homeobox A10 | 0.049 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.048 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.047 | ||
| SNX33 | sorting nexin 33 | 0.046 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.046 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.046 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.044 | ||
| NCK1 | NCK adaptor protein 1 | 0.043 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.043 | ||
| SH3D19 | SH3 domain containing 19 | 0.043 | ||
| HOXB9 | homeobox B9 | 0.043 | ||
| WNT3A | wingless-type MMTV integration site family, member 3A | 0.042 | Human | |
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.042 | ||
| PDGFC | platelet derived growth factor C | 0.041 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.040 | ||
| HOXA4 | homeobox A4 | 0.040 | Human | |
| PACSIN3 | protein kinase C and casein kinase substrate in neurons 3 | 0.039 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.039 | Mouse | |
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.038 | ||
| ACVR1 | activin A receptor, type I | 0.038 | Human | |
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.037 | Human | |
| GAST | gastrin | 0.037 | ||
| BMP4 | bone morphogenetic protein 4 | 0.037 | ||
| HOXA2 | homeobox A2 | 0.036 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.036 | ||
| HOXC10 | homeobox C10 | 0.036 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.036 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.036 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.035 | ||
| MUC1 | mucin 1, cell surface associated | 0.034 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.034 | ||
| CLDN1 | claudin 1 | 0.034 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.033 | ||
| SMAD1 | SMAD family member 1 | 0.032 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.031 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.031 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.030 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.030 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.030 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.029 | ||
| YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 0.029 | ||
| JAG2 | jagged 2 | 0.029 | ||
| SMAD6 | SMAD family member 6 | 0.028 | ||
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.028 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.028 | ||
| TNC | tenascin C | 0.027 | ||
| ELF5 | E74-like factor 5 (ets domain transcription factor) | 0.027 | ||
| NOTCH2NL | notch 2 N-terminal like | 0.027 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.026 | ||
| PLXDC1 | plexin domain containing 1 | 0.026 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.026 | ||
| MXRA5 | matrix-remodelling associated 5 | 0.025 | ||
| BMP1 | bone morphogenetic protein 1 | 0.025 | ||
| LIN7A | lin-7 homolog A (C. elegans) | 0.024 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.024 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.023 | Rat | |
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.023 | ||
| NDP | Norrie disease (pseudoglioma) | 0.023 | ||
| CCND1 | cyclin D1 | 0.023 | ||
| ANGPT1 | angiopoietin 1 | 0.023 | ||
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.023 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.023 | Human | |
| PCDH9 | protocadherin 9 | 0.023 | ||
| EPHB2 | EPH receptor B2 | 0.022 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.022 | ||
| ALK | anaplastic lymphoma receptor tyrosine kinase | 0.022 | ||
| FGF18 | fibroblast growth factor 18 | 0.022 | ||
| HOXA6 | homeobox A6 | 0.022 | Human | |
| ARHGAP5 | Rho GTPase activating protein 5 | 0.021 | ||
| BGN | biglycan | 0.021 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.020 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.020 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.020 | Human | |
| NRP2 | neuropilin 2 | 0.019 | ||
| INHBA | inhibin, beta A | 0.019 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.019 | ||
| BMP2 | bone morphogenetic protein 2 | 0.019 | ||
| ADAM12 | ADAM metallopeptidase domain 12 | 0.019 | Human | |
| MAML1 | mastermind-like 1 (Drosophila) | 0.018 | ||
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.018 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.018 | ||
| GYPC | glycophorin C (Gerbich blood group) | 0.018 | ||
| HOXA3 | homeobox A3 | 0.018 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.017 | ||
| HAP1 | huntingtin-associated protein 1 | 0.017 | ||
| COL6A3 | collagen, type VI, alpha 3 | 0.017 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.017 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.017 | Human | |
| FBLN1 | fibulin 1 | 0.017 | ||
| VEGFC | vascular endothelial growth factor C | 0.017 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.016 | ||
| RARA | retinoic acid receptor, alpha | 0.016 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.016 | ||
| STC2 | stanniocalcin 2 | 0.016 | ||
| NOTCH2 | notch 2 | 0.016 | Human | |
| HOXC4 | homeobox C4 | 0.016 | Human | |
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.015 | ||
| HOXC8 | homeobox C8 | 0.015 | Human | |
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.015 | ||
| HOXB4 | homeobox B4 | 0.015 | Human | |
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.014 | ||
| C16orf53 | chromosome 16 open reading frame 53 | 0.014 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.014 | ||
| LNX1 | ligand of numb-protein X 1 | 0.014 | ||
| FSTL1 | follistatin-like 1 | 0.014 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.014 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.014 | ||
| COL11A1 | collagen, type XI, alpha 1 | 0.014 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.014 | ||
| HOXB2 | homeobox B2 | 0.014 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.014 | ||
| A2M | alpha-2-macroglobulin | 0.014 | ||
| HOXD8 | homeobox D8 | 0.014 | Human | |
| SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.013 | ||
| F11R | F11 receptor | 0.013 | ||
| TJP3 | tight junction protein 3 (zona occludens 3) | 0.013 | ||
| ANAPC1 | anaphase promoting complex subunit 1 | 0.013 | ||
| COL7A1 | collagen, type VII, alpha 1 | 0.013 | ||
| GDF10 | growth differentiation factor 10 | 0.013 | ||
| COL4A5 | collagen, type IV, alpha 5 | 0.013 | ||
| WIF1 | WNT inhibitory factor 1 | 0.013 | ||
| EFS | embryonal Fyn-associated substrate | 0.013 | ||
| XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.013 | ||
| FOXF2 | forkhead box F2 | 0.013 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.013 | ||
| NID1 | nidogen 1 | 0.013 | ||
| EGFR | epidermal growth factor receptor | 0.013 | ||
| HOXC5 | homeobox C5 | 0.013 | Human | |
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.013 | ||
| FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.012 | ||
| SMAD2 | SMAD family member 2 | 0.012 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.012 | ||
| HOXD10 | homeobox D10 | 0.012 | ||
| THBS2 | thrombospondin 2 | 0.012 | Human | |
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.012 | ||
| LAMA5 | laminin, alpha 5 | 0.012 | ||
| PRRX1 | paired related homeobox 1 | 0.012 | ||
| FRZB | frizzled-related protein | 0.012 | Human | |
| HOXC11 | homeobox C11 | 0.012 | ||
| COL10A1 | collagen, type X, alpha 1 | 0.012 | ||
| PPAP2B | phosphatidic acid phosphatase type 2B | 0.012 | ||
| HOXC9 | homeobox C9 | 0.012 | ||
| PGR | progesterone receptor | 0.012 | ||
| NPHP1 | nephronophthisis 1 (juvenile) | 0.012 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.012 | ||
| CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0.012 | ||
| TNFSF11 | tumor necrosis factor (ligand) superfamily, member 11 | 0.012 | ||
| PTHLH | parathyroid hormone-like hormone | 0.012 | ||
| POSTN | periostin, osteoblast specific factor | 0.012 | ||
| RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 0.012 | ||
| TWIST1 | twist homolog 1 (Drosophila) | 0.011 | ||
| FNDC1 | fibronectin type III domain containing 1 | 0.011 | ||
| ECM1 | extracellular matrix protein 1 | 0.011 | ||
| KRT15 | keratin 15 | 0.011 | ||
| IHH | Indian hedgehog | 0.011 | ||
| CDC27 | cell division cycle 27 homolog (S. cerevisiae) | 0.011 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.011 | ||
| HOXA1 | homeobox A1 | 0.011 | ||
| OSMR | oncostatin M receptor | 0.011 | ||
| WNT10A | wingless-type MMTV integration site family, member 10A | 0.011 | Human | |
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.011 | ||
| HOXB8 | homeobox B8 | 0.011 | Human | |
| FZD2 | frizzled homolog 2 (Drosophila) | 0.011 | Human | |
| VWF | von Willebrand factor | 0.011 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.011 | ||
| CCND2 | cyclin D2 | 0.011 | ||
| EPB41 | erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) | 0.011 | ||
| GPR124 | G protein-coupled receptor 124 | 0.011 | ||
| MXRA8 | matrix-remodelling associated 8 | 0.011 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.011 | ||
| POU2F3 | POU class 2 homeobox 3 | 0.011 | ||
| AMOT | angiomotin | 0.010 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.010 | ||
| ITGA6 | integrin, alpha 6 | 0.010 | ||
| SFRP2 | secreted frizzled-related protein 2 | 0.010 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.010 | ||
| SPP1 | secreted phosphoprotein 1 | 0.010 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.010 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.010 | ||
| THY1 | Thy-1 cell surface antigen | 0.010 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.010 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.010 | ||
| CTGF | connective tissue growth factor | 0.010 | ||
| FURIN | furin (paired basic amino acid cleaving enzyme) | 0.010 |